Korea S.E.
18:00:00 2024-05-13 EDT
5-day change
1st Jan Change
5,740
KRW
+4.17%
-0.17%
-6.82%
Biotoxtech Co., Ltd.(KOSDAQ:A086040) dropped from S&P Global BMI Index
September 19, 2022 at 12:00 am
Biotoxtech Co., Ltd.(KOSDAQ:A086040) dropped from S&P Global BMI Index
Biotoxtech Co., Ltd.(KOSDAQ:A086040) dropped from S&P Global BMI Index
22-09-19
CI
Biotoxtech Co., Ltd.(KOSDAQ:A086040) added to S&P Global BMI Index
21-09-20
CI
Biotoxtech Co., Ltd. announced that it has received KRW 18 billion in funding from BNK Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd. and other investors
21-08-23
CI
Biotoxtech Co., Ltd. announced that it expects to receive KRW 18 billion in funding from BNK Securities Co., Ltd., Investment Arm, Mirae Asset Securities Co., Ltd. and other investors
21-08-19
CI
Sung Bin Hong, Chief Executive Officer of Biomix Co., Ltd. cancelled the acquisition of 40% stake in Biomix Co., Ltd. from Biotoxtech Co., Ltd..
21-01-16
CI
Sung Bin Hong, Chief Executive Officer of Biomix Co., Ltd. agreed to acquire 40% stake in Biomix Co., Ltd. from Biotoxtech Co., Ltd. for KRW 5.4 billion.
20-01-16
CI
Biotoxtech Co., Ltd.(KOSDAQ:A086040) dropped from S&P Global BMI Index
19-09-23
CI
Biotoxtech Co., Ltd.(KOSDAQ:A086040) added to S&P Global BMI Index
18-09-24
CI
WOOJUNG BIO, Inc. announced that it has received KRW 10 billion in funding from a group of investors
18-08-09
CI
WOOJUNG BIO, Inc. announced that it expects to receive KRW 10 billion in funding from a group of investors
18-08-07
CI
Biotoxtech Co., Ltd. acquired 40% stake in Biomix Co., Ltd. for KRW 8 billion.
17-10-15
CI
Tranche Update on Biotoxtech Co., Ltd.'s Equity Buyback Plan announced on February 25, 2016.
16-03-17
CI
Biotoxtech Co., Ltd.’s Equity Buyback announced on February 25, 2016 has expired with 50,000 shares, representing 0.35% for KRW 292.52 million.
16-03-17
CI
Biotoxtech Co., Ltd. announces an Equity Buyback for KRW 300 million worth of its shares.
16-02-24
CI
Biotoxtech Co., Ltd. authorizes a Buyback Plan.
16-02-24
CI
Allianz Global Investors Korea Limited acquired 3.22% stake in Biotoxtech Co., Ltd..
14-11-19
CI
Biotoxtech Co., Ltd's Equity Buyback announced on April 9, 2012 has expired.
13-10-11
CI
Biotoxtech Co., Ltd. Announces Financial Results for the Year Ended December 31, 2012
13-06-10
CI
Biotoxtech Co., Ltd.'s Equity Buyback Plan Extended till October 11, 2013
13-04-11
CI
Biotoxtech Co., Ltd. acquired 60% stake in Sejong Venture Partners Co., Ltd. for KRW 3 billion.
13-03-13
CI
Biotoxtech Co., Ltd.'s Equity Buyback Plan Extended till April 11, 2013
12-10-11
CI
Biotoxtech Co., Ltd. announces an Equity Buyback in the amount of KRW1000 mm
12-04-08
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Biotoxtech Co., Ltd. is a Korea-based company engaged in the research of non-clinical evaluation business. The Company provides safety evaluation research, efficacy evaluation research and analysis research. Its safety evaluation research business provides general toxicity tests, local toxicity tests, reproductive and development tests, genotoxicity tests, immunotoxicity tests, carcinogenicity tests, safety pharmacology tests, ecotoxicology tests, histopathology tests and hematology tests. Its efficacy evaluation research business provides efficacy evaluation of medical supplies, health supplements and cosmetics. Its analysis research business provides pharmacokinetics (PK) tests and toxicokinetics (TK) tests services, as well as validation and bio analysis services. On March 13, 2013, the Company acquired a 60% stake in its new established subsidiary.
More about the company
1st Jan change
Capi.
-6.82% 67M +29.47% 49.18B +0.99% 42.11B +50.47% 40.37B -5.26% 28.85B +13.59% 26.09B -22.72% 18.71B +8.46% 13.26B +32.07% 12.32B -0.85% 11.99B
Other Biotechnology & Medical Research
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BIOTOXTECH CO., LTD. 
